PEP005 (Ingenol Mebutate) Gel 0.05%
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PEP005 (Ingenol Mebutate) Gel 0.05%, covering 2012-05-28 to 2012-05-28. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Pharmacokinetics of PEP005 (Ingenol Mebutate) Gel, 0.05%, When Applied in a Maximal Use Setting to the Dorsal Aspect of the Forearm in Patients With Actinic Keratosis [Phase 2]